Sharps Technology Inc. (STSS)
NASDAQ: STSS
· Real-Time Price · USD
5.00
-0.12 (-2.34%)
At close: Aug 15, 2025, 1:27 PM
Company Description
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States.
It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications.
The company was incorporated in 2017 and is based in Melville, New York.
Sharps Technology Inc.

Country | United States |
IPO Date | Apr 14, 2022 |
Industry | Medical - Instruments & Supplies |
Sector | Healthcare |
Employees | 55 |
CEO | Robert M. Hayes |
Contact Details
Address: 105 Maxess Road Melville, New York United States | |
Website | https://sharpstechnology.com |
Stock Details
Ticker Symbol | STSS |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001737995 |
CUSIP Number | 82003F309 |
ISIN Number | US82003F1012 |
Employer ID | 82-3751728 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Robert M. Hayes | Chief Executive Officer & Director |
Andrew R. Crescenzo CPA | Chief Financial Officer |
Frank Parrado | Corporate Controller |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Aug 14, 2025 | SCHEDULE 13G/A | [Amend] Filing |
Aug 13, 2025 | 10-Q | Quarterly Report |
Aug 05, 2025 | DEFR14A | Filing |
Aug 05, 2025 | DEFR14A | Filing |
Jul 28, 2025 | DEF 14A | Filing |
Jul 18, 2025 | PRER14A | Filing |
Jul 18, 2025 | 8-K | Current Report |
Jul 18, 2025 | 4 | Filing |
Jul 03, 2025 | 8-K | Current Report |
Jul 03, 2025 | PRE 14A | Filing |